this post was submitted on 28 Jul 2023
154 points (99.4% liked)
Science
1224 readers
5 users here now
This magazine is dedicated to discussions on scientific discoveries, research, and theories across various fields, including physics, chemistry, biology, astronomy, and more. Whether you are a scientist, a science enthusiast, or simply curious about the world around us, this is the place for you. Here you can share your knowledge, ask questions, and engage in discussions on a wide range of scientific topics. From the latest breakthroughs to historical discoveries and ongoing research, this category covers a wide range of topics related to science.
founded 2 years ago
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
I work in drug development, and have done a lot of work in topical drug development, specifically for skin diseases. Psoriasis gets most of the attention, but there's a lot of work being done on other skin diseases, as well
"Eczema" is kind of a catch-all term for a group of diseases, which is one of the reasons treatment is so difficult. One kind is often mistaken for (or even indistinguishable from) another. The most common, though, is atopic dermatitis (which is hilarious when you look up the etymology).
So that said.... Have you tried JAK inhibitors? Ruxolitinib is one of the best ones, formulated as a cream called Opzelura. It's at least good for flare ups.
Unfortunately, there aren't really any good drugs for preventing it. If you want company on that one, talk to the asthma community.
But.... There is work being done. I've worked on it. I've had companies spend millions on the work. I haven't seen anything very promising, but maybe you can take some comfort that there are frustrated scientists working on it, and pharma companies poised to take all of your money once something is found.